A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Conditions: Locally Advanced Alveolar Soft Part Sarcoma; Metastatic Alveolar Soft Part Sarcoma; Locally Advanced Non Small Cell Lung Cancer; Metastatic Non Small Cell Lung Cancer; Locally Advanced Small Cell Lung Cancer; Metastatic Small Cell Lung Cancer; Locally Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma; Locally Advanced Melanoma; Metastatic Melanoma Interventions: Drug: Atezolizumab Sponsors: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Research | Sarcomas | Skin Cancer | Study